Literature DB >> 18285287

Long-term viability of coronary artery smooth muscle cells on poly(L-lactide-co-epsilon-caprolactone) nanofibrous scaffold indicates its potential for blood vessel tissue engineering.

Yixiang Dong1, Thomas Yong, Susan Liao, Casey K Chan, S Ramakrishna.   

Abstract

Biodegradable polymer nanofibres have been extensively studied as cell culture scaffolds in tissue engineering. However, long-term in vitro studies of cell-nanofibre interactions were rarely reported and successful organ regeneration using tissue engineering techniques may take months (e.g. blood vessel tissue engineering). Understanding the long-term interaction between cells and nanofibrous scaffolds (NFS) is crucial in material selection, design and processing of the tissue engineering scaffolds. In this study, poly(L-lactide-co-epsilon-caprolactone) [P(LLA-CL)] (70:30) copolymer NFS were produced by electrospinning. Porcine coronary artery smooth muscle cells (PCASMCs) were seeded and cultured on the scaffold to evaluate cell-nanofibre interactions for up to 105 days. A favourable interaction between this scaffold and PCASMCs was demonstrated by cell viability assay, scanning electron microscopy, histological staining and extracellular matrix (ECM) secretion. Degradation behaviours of the scaffolds with or without PCASMC culture were determined by mechanical testing and gel permeation chromatography (GPC). The results showed that the PCASMCs attached and proliferated well on the P(LLA-CL) NFS. Large amount of ECM protein secretion was observed after 50 days of culture. Multilayers of aligned oriented PCASMCs were formed on the scaffold after two months of in vitro culture. In the degradation study, the PCASMCs were not shown to significantly increase the degradation rate of the scaffolds for up to 105 days of culture. The in vitro degradation time of the scaffold could be as long as eight months by extrapolating the results from GPC. These observations further supported the potential use of the P(LLA-CL) nanofibre in blood vessel tissue engineering.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18285287      PMCID: PMC2607431          DOI: 10.1098/rsif.2007.1354

Source DB:  PubMed          Journal:  J R Soc Interface        ISSN: 1742-5662            Impact factor:   4.118


  38 in total

1.  Clinical autologous in vitro endothelialization of infrainguinal ePTFE grafts in 100 patients: a 9-year experience.

Authors:  M Deutsch; J Meinhart; T Fischlein; P Preiss; P Zilla
Journal:  Surgery       Date:  1999-11       Impact factor: 3.982

2.  Novel vascular graft grown within recipient's own peritoneal cavity.

Authors:  J H Campbell; J L Efendy; G R Campbell
Journal:  Circ Res       Date:  1999 Dec 3-17       Impact factor: 17.367

Review 3.  Molecular mechanisms in intimal hyperplasia.

Authors:  A C Newby; A B Zaltsman
Journal:  J Pathol       Date:  2000-02       Impact factor: 7.996

4.  Remodeling of an acellular collagen graft into a physiologically responsive neovessel.

Authors:  T Huynh; G Abraham; J Murray; K Brockbank; P O Hagen; S Sullivan
Journal:  Nat Biotechnol       Date:  1999-11       Impact factor: 54.908

Review 5.  Tissue engineering of vascular grafts.

Authors:  A Ratcliffe
Journal:  Matrix Biol       Date:  2000-08       Impact factor: 11.583

6.  Physical characterization of vascular grafts cultured in a bioreactor.

Authors:  Laura Buttafoco; Paula Engbers-Buijtenhuijs; Andre A Poot; Piet J Dijkstra; Istvan Vermes; Jan Feijen
Journal:  Biomaterials       Date:  2005-11-11       Impact factor: 12.479

7.  Tissue-engineered vascular grafts composed of marine collagen and PLGA fibers using pulsatile perfusion bioreactors.

Authors:  Sung In Jeong; So Yeon Kim; Seong Kwan Cho; Moo Sang Chong; Kyung Soo Kim; Hyuck Kim; Sang Bong Lee; Young Moo Lee
Journal:  Biomaterials       Date:  2006-11-16       Impact factor: 12.479

8.  Antithrombogenic property of bone marrow mesenchymal stem cells in nanofibrous vascular grafts.

Authors:  Craig K Hashi; Yiqian Zhu; Guo-Yuan Yang; William L Young; Benjamin S Hsiao; Karin Wang; Benjamin Chu; Song Li
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-05       Impact factor: 11.205

9.  Electrospun PLGA nanofiber scaffolds for articular cartilage reconstruction: mechanical stability, degradation and cellular responses under mechanical stimulation in vitro.

Authors:  Ho Joon Shin; Chang Hun Lee; In Hee Cho; Young-Jick Kim; Yong-Jae Lee; In Ae Kim; Ki-Dong Park; Nobuhiko Yui; Jung-Woog Shin
Journal:  J Biomater Sci Polym Ed       Date:  2006       Impact factor: 3.517

10.  Production of extracellular matrix components in tissue-engineered blood vessels.

Authors:  Sepideh Heydarkhan-Hagvall; Maricris Esguerra; Gisela Helenius; Rigmor Söderberg; Bengt R Johansson; Bo Risberg
Journal:  Tissue Eng       Date:  2006-04
View more
  6 in total

1.  An optical method to quantify the density of ligands for cell adhesion receptors in three-dimensional matrices.

Authors:  Dimitrios S Tzeranis; Amit Roy; Peter T C So; Ioannis V Yannas
Journal:  J R Soc Interface       Date:  2010-07-29       Impact factor: 4.118

2.  NanoBioInterface: a multidisciplinary challenge.

Authors:  C James Kirkpatrick; William Bonfield
Journal:  J R Soc Interface       Date:  2009-12-02       Impact factor: 4.118

Review 3.  Scaffolds in vascular regeneration: current status.

Authors:  Neelima Thottappillil; Prabha D Nair
Journal:  Vasc Health Risk Manag       Date:  2015-01-19

4.  Electrospun nanofibrous SF/P(LLA-CL) membrane: a potential substratum for endothelial keratoplasty.

Authors:  Junzhao Chen; Chenxi Yan; Mengyu Zhu; Qinke Yao; Chunyi Shao; Wenjuan Lu; Jing Wang; Xiumei Mo; Ping Gu; Yao Fu; Xianqun Fan
Journal:  Int J Nanomedicine       Date:  2015-05-05

5.  Additive Manufacturing of Patient-Customizable Scaffolds for Tubular Tissues Using the Melt-Drawing Method.

Authors:  Yu Jun Tan; Xipeng Tan; Wai Yee Yeong; Shu Beng Tor
Journal:  Materials (Basel)       Date:  2016-11-03       Impact factor: 3.623

6.  Suture retention strength of P(LLA-CL) tissue-engineered vascular grafts.

Authors:  Xin Meng; Xiaofeng Wang; Yongchao Jiang; Bo Zhang; Kun Li; Qian Li
Journal:  RSC Adv       Date:  2019-07-09       Impact factor: 4.036

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.